Fabrication of Hyaluronic Acid‐Targeted Supramolecular Delivery Platform With pH and ROS‐Responsive Drug Release
Macromolecular Rapid Communications · 2025
DOI: 10.1002/marc.202500201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Rapid Communications, 2025. Verfasst von Kaixuan Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China. Hauptthemen laut MEDLINE: Hyaluronic Acid, Reactive Oxygen Species, Antineoplastic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
A supramolecular drug delivery system is fabricated here based on the assembly of β‐cyclodextrin‐modified hyaluronic acid (HACD) and ferrocene (Fc) with pH‐sensitive polyhistidine (PHIS). The system demonstrates efficient encapsulation of hydrophobic anticancer drugs with high and stable drug loading capacity. The drug‐loaded nanoparticles utilize HACD as the hydrophilic corona, enabling active tumor targeting through CD44 receptor‐mediated endocytosis and exhibiting dual stimuli‐responsive release properties (ROS and pH). In the tumor microenvironment characterized by elevated ROS levels and acidic pH, the nanoparticles undergo structural disassembly, switching from controlled release to rapid drug liberation. Blank nanoparticles exhibit excellent biocompatibility, while drug‐loaded formulations demonstrate selective cytotoxicity with significantly reduced toxicity toward normal cells HFF‐1 and enhanced therapeutic efficacy against HeLa cancer cells. This nanoplatform significantly improves the aqueous solubility and biocompatibility of hydrophobic drugs, achieving intelligent delivery and double‐modal stimulus‐responsive release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, P. R. China.
- Hangzhou SynRx Therapeutics Biomedical Technology Co., Hangzhou, Zhejiang, 311121, P. R. China.
ORCID-Profile: Ruyi Sun
Zitieren
APA
Jiang, K., Wu, W., Xie, M., He, H., & Sun, R. (2025). Fabrication of Hyaluronic Acid‐Targeted Supramolecular Delivery Platform With pH and ROS‐Responsive Drug Release. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202500201
Vancouver
Jiang K, Wu W, Xie M, He H, Sun R. Fabrication of Hyaluronic Acid‐Targeted Supramolecular Delivery Platform With pH and ROS‐Responsive Drug Release. Macromolecular Rapid Communications. 2025. doi:10.1002/marc.202500201
BibTeX
@article{Jiang2025,
author = {Jiang, Kaixuan and Wu, Wenhui and Xie, Meiran and He, Hu and Sun, Ruyi},
title = {Fabrication of Hyaluronic Acid‐Targeted Supramolecular Delivery Platform With pH and ROS‐Responsive Drug Release},
journal = {Macromolecular Rapid Communications},
year = {2025},
doi = {10.1002/marc.202500201}
}
EUVIMED